Loss of MicroRNA Cluster MiR-29a/b-1 in Sporadic Alzheimer's Disease Correlates with Increased BACE1/beta-secretase Expression

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Apr 25

PMID 18434550

Citations 602

Authors

Sebastien S Hebert

Katrien Horre

Laura Nicolai

Aikaterini S Papadopoulou

Wim Mandemakers

Asli N Silahtaroglu

Sakari Kauppinen

Andre Delacourte

Bart De Strooper

Affiliations

Soon will be listed here.

Abstract

Although the role of APP and PSEN genes in genetic Alzheimer's disease (AD) cases is well established, fairly little is known about the molecular mechanisms affecting Abeta generation in sporadic AD. Deficiency in Abeta clearance is certainly a possibility, but increased expression of proteins like APP or BACE1/beta-secretase may also be associated with the disease. We therefore investigated changes in microRNA (miRNA) expression profiles of sporadic AD patients and found that several miRNAs potentially involved in the regulation of APP and BACE1 expression appeared to be decreased in diseased brain. We show here that miR-29a, -29b-1, and -9 can regulate BACE1 expression in vitro. The miR-29a/b-1 cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein. Similar correlations between expression of this cluster and BACE1 were found during brain development and in primary neuronal cultures. Finally, we provide evidence for a potential causal relationship between miR-29a/b-1 expression and Abeta generation in a cell culture model. We propose that loss of specific miRNAs can contribute to increased BACE1 and Abeta levels in sporadic AD.

Citing Articles

Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease.

Counts S, Beck J, Maloney B, Malek-Ahmadi M, Ginsberg S, Mufson E Alzheimers Dement. 2025; 21(2):e70019.

PMID: 40008917 PMC: 11863362. DOI: 10.1002/alz.70019.

Molecular profiling of neuronal extracellular vesicles reveals brain tissue specific signals.

Kalia V, Jackson G, Dominguez R, Pinto-Pacheco B, Bloomquist T, Furnari J medRxiv. 2025; .

PMID: 39974146 PMC: 11839008. DOI: 10.1101/2025.01.23.25320909.

Good things come in small packages: The discovery of small RNAs in the smallest animal model.

Ma C, Lo S, Chin-Ming Tan B Biomed J. 2025; 48(1):100832.

PMID: 39952406 PMC: 11893309. DOI: 10.1016/j.bj.2025.100832.

Application of the Trend of miRNA Expression Levels in APP/PS1 Mice Plasma for the Early Diagnosis of Alzheimer's Disease.

Zhang Y, Wang Y, Zhao F Mol Neurobiol. 2025; .

PMID: 39937416 DOI: 10.1007/s12035-025-04743-6.

Role of exercise on ncRNAs and exosomal ncRNAs in preventing neurodegenerative diseases: a narrative review.

Liu S, Zhang R, Hallajzadeh J Mol Med. 2025; 31(1):51.

PMID: 39920595 PMC: 11803956. DOI: 10.1186/s10020-025-01091-y.

References

Bilen J, Liu N, Burnett B, Pittman R, Bonini N . MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell. 2006; 24(1):157-63. DOI: 10.1016/j.molcel.2006.07.030. View

Zacchetti D, Chieregatti E, Bettegazzi B, Mihailovich M, Sousa V, Grohovaz F . BACE1 expression and activity: relevance in Alzheimer's disease. Neurodegener Dis. 2007; 4(2-3):117-26. DOI: 10.1159/000101836. View

Schaefer A, OCarroll D, Tan C, Hillman D, Sugimori M, Llinas R . Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med. 2007; 204(7):1553-8. PMC: 2118654. DOI: 10.1084/jem.20070823. View

Griffiths-Jones S . The microRNA Registry. Nucleic Acids Res. 2003; 32(Database issue):D109-11. PMC: 308757. DOI: 10.1093/nar/gkh023. View

Laird F, Cai H, Savonenko A, Farah M, He K, Melnikova T . BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci. 2005; 25(50):11693-709. PMC: 2564291. DOI: 10.1523/JNEUROSCI.2766-05.2005. View

Sun A, Koelsch G, Tang J, Bing G . Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Exp Neurol. 2002; 175(1):10-22. DOI: 10.1006/exnr.2002.7875. View

Miska E, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P . Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004; 5(9):R68. PMC: 522875. DOI: 10.1186/gb-2004-5-9-r68. View

Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia M . miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2006; 1(2):106-13. DOI: 10.4161/rna.1.2.1066. View

Niwa R, Zhou F, Li C, Slack F . The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev Biol. 2008; 315(2):418-25. PMC: 2307910. DOI: 10.1016/j.ydbio.2007.12.044. View

10.

Yamamoto M, Kiyota T, Horiba M, Buescher J, Walsh S, Gendelman H . Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol. 2007; 170(2):680-92. PMC: 1851864. DOI: 10.2353/ajpath.2007.060378. View

11.

Boehm M, Slack F . A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005; 310(5756):1954-7. DOI: 10.1126/science.1115596. View

12.

Sempere L, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V . Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5(3):R13. PMC: 395763. DOI: 10.1186/gb-2004-5-3-r13. View

13.

Silahtaroglu A, Nolting D, Dyrskjot L, Berezikov E, Moller M, Tommerup N . Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc. 2007; 2(10):2520-8. DOI: 10.1038/nprot.2007.313. View

14.

Wang W, Rajeev B, Stromberg A, Ren N, Tang G, Huang Q . The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008; 28(5):1213-23. PMC: 2837363. DOI: 10.1523/JNEUROSCI.5065-07.2008. View

15.

Lukiw W . Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport. 2007; 18(3):297-300. DOI: 10.1097/WNR.0b013e3280148e8b. View

16.

Rogaev E, Sherrington R, Rogaeva E, Levesque G, Ikeda M, Liang Y . Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995; 376(6543):775-8. DOI: 10.1038/376775a0. View

17.

Rossner S, Sastre M, Bourne K, Lichtenthaler S . Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Prog Neurobiol. 2006; 79(2):95-111. DOI: 10.1016/j.pneurobio.2006.06.001. View

18.

Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S . Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem. 2005; 280(35):30797-806. DOI: 10.1074/jbc.M505249200. View

19.

Esselens C, Oorschot V, Baert V, Raemaekers T, Spittaels K, Serneels L . Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J Cell Biol. 2004; 166(7):1041-54. PMC: 2172014. DOI: 10.1083/jcb.200406060. View

20.

Hebert S, De Strooper B . Molecular biology. miRNAs in neurodegeneration. Science. 2007; 317(5842):1179-80. DOI: 10.1126/science.1148530. View